Northern Trust’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-197,896
Closed -$3.64M 4536
2020
Q4
$3.64M Sell
197,896
-12,567
-6% -$231K ﹤0.01% 2857
2020
Q3
$3.86M Buy
210,463
+15,182
+8% +$278K ﹤0.01% 2698
2020
Q2
$2.92M Buy
195,281
+27,894
+17% +$418K ﹤0.01% 2824
2020
Q1
$2.65M Buy
167,387
+3,306
+2% +$52.3K ﹤0.01% 2689
2019
Q4
$2.67M Buy
164,081
+3,806
+2% +$61.8K ﹤0.01% 2946
2019
Q3
$2.38M Sell
160,275
-9,998
-6% -$149K ﹤0.01% 3006
2019
Q2
$2.82M Buy
170,273
+8,101
+5% +$134K ﹤0.01% 2870
2019
Q1
$2.81M Buy
162,172
+70
+0% +$1.21K ﹤0.01% 2883
2018
Q4
$2.86M Sell
162,102
-2,213
-1% -$39.1K ﹤0.01% 2852
2018
Q3
$2.98M Buy
164,315
+82,557
+101% +$1.5M ﹤0.01% 2988
2018
Q2
$1.6M Buy
81,758
+43,778
+115% +$856K ﹤0.01% 3315
2018
Q1
$667K Buy
37,980
+7,076
+23% +$124K ﹤0.01% 3494
2017
Q4
$347K Buy
30,904
+868
+3% +$9.75K ﹤0.01% 3642
2017
Q3
$320K Hold
30,036
﹤0.01% 3659
2017
Q2
$263K Sell
30,036
-102,447
-77% -$897K ﹤0.01% 3713
2017
Q1
$1.56M Sell
132,483
-829
-0.6% -$9.78K ﹤0.01% 3192
2016
Q4
$1.75M Sell
133,312
-2,247
-2% -$29.4K ﹤0.01% 3163
2016
Q3
$1.97M Buy
135,559
+493
+0.4% +$7.15K ﹤0.01% 3081
2016
Q2
$1.62M Buy
135,066
+17,081
+14% +$205K ﹤0.01% 3153
2016
Q1
$2.2M Buy
117,985
+5,017
+4% +$93.5K ﹤0.01% 2930
2015
Q4
$2.43M Buy
112,968
+1,237
+1% +$26.6K ﹤0.01% 2943
2015
Q3
$1.89M Buy
111,731
+85,480
+326% +$1.45M ﹤0.01% 3085
2015
Q2
$985K Buy
26,251
+16,832
+179% +$632K ﹤0.01% 3353
2015
Q1
$296K Buy
+9,419
New +$296K ﹤0.01% 3759